Epristeride sustained-release pellets and preparation method thereof

A technology of Aprelate and sustained-release pellets, which is applied in the field of Aprelate sustained-release pellets and its preparation, which can solve the problems of packaging, transportation, and storage inconvenience, low drug release stability, and large gastrointestinal irritation and other issues, to achieve the effect of improving bioavailability, small individual differences, and easy absorption

Inactive Publication Date: 2016-05-25
HARBIN SHENGJI PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, among the Aprellide drugs for the treatment of benign prostatic hyperplasia on the market, there are low drug release stability, high i

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Epristeride sustained-release pellets and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0027] Example 1

[0028] A sustained-release pellet of Aplite, comprising a coating layer and a drug-containing pellet; it is characterized in that: the coating layer is wrapped on the outer side of the drug-containing pellet; the coating layer comprises: 35-175mg Ute Qi NE30D, 5-53 mg of talc; the drug-containing pellets include: 5 mg of Epilite, 80 mg of blank core, 195-250 mg of filler, 10-50 mg of lubricant, and 5-25 mg of binder.

[0029] The coating layer also includes a trace amount of one or two of sodium lauryl sulfate and polyethylene glycol.

[0030] The preferred weight ratio in the coating layer is: 132mg Eudragit NE30D, 7mg talc.

[0031] The preferred weight ratio in the drug-containing pellets is: 5 mg of Eplite, 80 mg of blank pill core, 235 mg of filler, 20 mg of lubricant, and 10 mg of binder.

[0032] The filler is microcrystalline cellulose, the lubricant is talc, and the binder is hypromellose.

Example Embodiment

[0033] Example 2

[0034] Its production method includes the following steps:

[0035] Step 1: Material preparation: According to the above-mentioned mass ratio, use a pulverizer to pulverize the Eplite, and pass it through a 100-mesh sieve;

[0036] Step 2: Mixing: Weigh Epilite and Microcrystalline Cellulose according to the above-mentioned mass ratio, put them into a three-dimensional mixer and mix for 30 minutes to make medicine subdivisions, and take them out for use;

[0037] Step 3: preparation of adhesive: weigh an appropriate amount of hypromellose according to the above-mentioned mass ratio, add an appropriate amount of hot water to prepare an adhesive with a concentration of 2%, for use;

[0038] Step 4: Pill making: put the medicine into the feeding tank of the centrifugal pill making machine, put the adhesive into the liquid supply tank, put the blank pill core in the pot, turn on the machine, adjust the parameters, and start spraying. When the pill ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses epristeride sustained-release pellets and a preparation method thereof. The epristeride sustained-release pellets comprise a coating layer, drug-containing pellets, Eudragit NE 30D, powdered steatile, sodium dodecyl sulfate or polyethylene glycol, epristeride, blank-pellets, a filler, a lubricant, and an adhesive. According to the invention, a novel sustained-release preparation and a pellets preparation are employed, sustained release means that by prolonging drug release rate of a drug in a dosage form, the absorption rate of the drug in human body is reduced, so that more stable treatment effect can be realized; the pellets have the advantage of large distribution area of the drug on surface of gastrointestinal tract, reduce irritation, increase bioavailability, and do not be influenced by gastric emptying influence, the drug can be uniformly absorbed by human body, individual difference is little; simultaneous application of two advanced technologies enhances the technical advantage of the epristeride sustained-release pellets; compared with oral liquid, the epristeride sustained-release pellets have the advantages of good drug stability, convenient package, transport and storage, the preparation method is simple and easy to operate, and is suitable for industrial production.

Description

technical field [0001] The invention belongs to the field of chemical drug sustained-release preparations, and in particular relates to an aprelate sustained-release pellet and a preparation method thereof. Background technique [0002] Prostatic hyperplasia (BPH) is one of the common diseases of middle-aged and elderly men, and its incidence is increasing with the aging of the global population. The incidence of benign prostatic hyperplasia increases with age, but there may not be clinical symptoms when there are hyperplasia lesions. The urban incidence rate is higher than that in the rural areas, and racial differences also affect the degree of proliferation. [0003] There are many studies on the pathogenesis of benign prostatic hyperplasia, but the etiology has not yet been elucidated. It is known that benign prostatic hyperplasia must have two conditions: functioning testis and increasing age. In recent years, it has also been noticed that smoking, obesity and alcoho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/58A61K9/16A61K31/56A61P13/08
Inventor 马玉国
Owner HARBIN SHENGJI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap